Delayed luteolysis after intra-uterine infusions of nordihydroguaiaretic acid in the ewe.
Intrauterine administration of nordihydroguaiaretic acid (5 mg, bid. NDGA), an inhibitor of the enzyme 5-lipoxygenase, on days 10-14 of the oestrous cycle, maintained luteal function and delayed oestrus in the ewe. The duration (mean +/- SD) of the oestrous cycle in the treatment group (n = 4) was 24 +/- 1 days, which was significantly (P < 0.001) longer than that of 16 +/- 1 days in vehicle-treated controls (n = 4); plasma progesterone concentrations were also significantly (P < 0.01) higher in the treatment group. On days 13 and 14 of the cycle (oestrus = Day 0) in the control group large pulses of 13,14-dihydro-15-keto prostaglandin F2alpha (PGFM) were evident, with mean (+/- SD) maximum concentrations of 232.5 +/- 66 and 415 +/- 309 pg ml(-1), respectively. In the treatment group, however, concentrations of PGFM were below detection level (< 50 pg ml(-1)). Similarly, in the control group, oxytocin release was highly pulsatile, with mean (+/- SD) peak concentrations of 21.8 +/- 5 and 18.5 +/- 6 pg ml(-1) on days 13 and 14, respectively; these were significantly (P < 0.01) higher than values of 7.6 +/- 3 and 6.1 +/- 3 pg ml(-1) in NDGA-treated ewes, where pulses were of relatively low amplitude. These results suggest that 5-lipoxygenase products of arachidonic acid metabolism may be involved in the positive feedback mechanism between luteal oxytocin and uterine PGF2alpha during luteolysis in the ewe.
Cooke
R G
RG
Department of Veterinary Preclinical Sciences, University of Liverpool, South Wirral, Cheshire, UK. cooker@liv.ac.uk
Ahmad
N
N
D000818:Animals; D003338:Corpus Luteum / Q000187:drug effects* / Q000502:physiology*; D015237:Dinoprost / Q000031:analogs & derivatives / Q000378:metabolism; D004971:Estrus; D005260:Female; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology*; D009637:Masoprocol / Q000008:administration & dosage / Q000494:pharmacology*; D010121:Oxytocin / Q000378:metabolism; D010507:Periodicity; D011374:Progesterone / Q000097:blood; D012756:Sheep / Q000502:physiology*; D014599:Uterus / Q000187:drug effects*
D016859:Lipoxygenase Inhibitors; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D011374:Progesterone; D010121:Oxytocin; D009637:Masoprocol; D015237:Dinoprost